trending Market Intelligence /marketintelligence/en/news-insights/trending/NqymtbcsoMaFDoEGV0jv-Q2 content esgSubNav
In This List

Trump's drug czar pick Marino withdraws after outcry over weakening DEA


According to Market Intelligence, December 2022


Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes


Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook


Japan M&A By the Numbers: Q3 2022

Trump's drug czar pick Marino withdraws after outcry over weakening DEA

President Donald Trump disclosed in an Oct. 17 morning tweet that Rep. Tom Marino, R-Pa., was withdrawing his name from consideration as the director of National Drug Control Policy — the White House drug czar.

"Tom is a fine man and a great congressman," Trump added.

Marino came under fire after the Washington Post and CBS' "60 Minutes" revealed that the Pennsylvania congressman had pushed a bill through Congress that weakened the Drug Enforcement Administration's ability to rein in distributors selling opioids to rogue pharmacies.

There was a growing outcry from members of Congress for Marino to withdraw his name, including from Democrat Sen. Joe Manchin, whose home state of West Virginia has been plagued by the U.S. opioid crisis.

Manchin also introduced legislation that aims to repeal Marino's bill.

Trump told reporters Oct. 16 that he would review Marino's nomination. He also vowed to formalize his earlier declaration to make the opioid crisis a national emergency.